Literature DB >> 10573245

Oxygen therapy during exacerbations of chronic obstructive pulmonary disease.

A G Agustí1, M Carrera, F Barbé, A Muñoz, B Togores.   

Abstract

Venturi masks (VMs) and nasal prongs (NPs) are widely used to treat acute respiratory failure (ARF) in chronic obstructive pulmonary disease (COPD). In this study, these devices were compared in terms of their potentiality to worsen respiratory acidosis and their capacity to maintain adequate (> 90%) arterial oxygenation (Sa,O2) through time (approximately 24 h). In a randomized cross-over study, 18 consecutive COPD patients who required hospitalization because of ARF were studied. After determining baseline arterial blood gas levels (on room air), patients were randomized to receive oxygen therapy through a VM or NPs at the lowest possible inspiratory oxygen fraction that resulted in an initial Sa,O2 of > or = 90%. Arterial blood gas levels were measured again 30 min later (on O2), and Sa,O2 recorded using a computer during the subsequent approximately 24 h. Patients were then crossed-over to receive O2 therapy by means of the alternative device (NPs or VM), and the same measurements obtained again in the same order. It was observed that both the VM and NPs improved arterial oxygen tension (p<0.0001) to the same extent (p=NS), without any significant effect upon arterial carbon dioxide tension or pH. However, despite this adequate initial oxygenation, Sa,O2 was < 90% for 3.7+/-3.8 h using the VM and for 5.4+/-5.9 h using NPs (p<0.05). Regression analysis showed that the degree of arterial hypoxaemia (p<0.05) and arterial hypercapnia (p<0.05) present before starting O2 therapy and, particularly, the initial Sa,O2 achieved after initiation of O2 therapy (p<0.0001) enabled the time (in h) that patients would be poorly oxygenated (Sa,O2 < 90%) on follow-up to be predicted. These findings suggest that, in order to maintain an adequate (> 90%) level of arterial oxygenation in patients with chronic obstructive pulmonary disease and moderate acute respiratory failure: 1) the initial arterial oxygen saturation on oxygen should be maximized whenever possible by increasing the inspiratory oxygen fraction; 2) this strategy seems feasible because neither the VM nor NPs worsen respiratory acidosis significantly; and 3) the Venturi mask (better than nasal prongs) should be recommended.

Entities:  

Mesh:

Year:  1999        PMID: 10573245     DOI: 10.1034/j.1399-3003.1999.14d34.x

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  11 in total

Review 1.  Emergency oxygen therapy for the COPD patient.

Authors:  R Murphy; P Driscoll; R O'Driscoll
Journal:  Emerg Med J       Date:  2001-09       Impact factor: 2.740

Review 2.  COPD exacerbations.5: management.

Authors:  R Rodríguez-Roisin
Journal:  Thorax       Date:  2006-06       Impact factor: 9.139

3.  Intermediate care--Hospital-at-Home in chronic obstructive pulmonary disease: British Thoracic Society guideline.

Authors: 
Journal:  Thorax       Date:  2006-11-07       Impact factor: 9.139

Review 4.  Management of acute exacerbations of chronic obstructive pulmonary disease in the elderly : an appraisal of published evidence.

Authors:  Ken M Kunisaki; Kathryn L Rice; Dennis E Niewoehner
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

Review 5.  Chronic obstructive pulmonary disease: the clinical management of an acute exacerbation.

Authors:  J R Hurst; J A Wedzicha
Journal:  Postgrad Med J       Date:  2004-09       Impact factor: 2.401

Review 6.  Chronic obstructive pulmonary disease * 9: management of ventilatory failure in COPD.

Authors:  P K Plant; M W Elliott
Journal:  Thorax       Date:  2003-06       Impact factor: 9.139

7.  A proof of concept for continuous, non-invasive, free-living vital signs monitoring to predict readmission following an acute exacerbation of COPD: a prospective cohort study.

Authors:  Grace Hawthorne; Matthew Richardson; Neil J Greening; Dale Esliger; Samuel Briggs-Price; Emma J Chaplin; Lisa Clinch; Michael C Steiner; Sally J Singh; Mark W Orme
Journal:  Respir Res       Date:  2022-04-26

8.  Automated Oxygen Delivery in Hospitalized Patients with Acute Respiratory Failure: A Pilot Study.

Authors:  Foteini Malli; Stelios Boutlas; Nick Lioufas; Konstantinos I Gourgoulianis
Journal:  Can Respir J       Date:  2019-02-03       Impact factor: 2.409

Review 9.  Treatment of respiratory failure in COPD.

Authors:  Stephan Budweiser; Rudolf A Jörres; Michael Pfeifer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

10.  Effectiveness of high-flow nasal cannula oxygen therapy for acute respiratory failure with hypercapnia.

Authors:  Eun Sun Kim; Hongyeul Lee; Se Joong Kim; Jisoo Park; Yeon Joo Lee; Jong Sun Park; Ho Il Yoon; Jae Ho Lee; Choon-Taek Lee; Young-Jae Cho
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.